Table 3. Safety of oral immunotherapy during maintenance.
| Allergic reaction & symptom | No. | |
|---|---|---|
| Allergic reactions | ||
| <3 episodes | 16 | |
| ≥3 episodes | 3 | |
| No allergic reactions | 23 | |
| Symptoms | ||
| Mucocutaneous | 17 | |
| Respiratory | 7 | |
| Gastrointestinal | 3 | |
| Systemic reactions (at least 2 systems involved) | 2 | |
| Headaches | 1 | |